You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.
The INTERCEPT study showed the potential of broader genetic testing to personalize treatment approaches for cancer patients.
Inivata's Radar assay will be used to monitor circulating tumor DNA from multiple tumor types in trial participants following treatment with Maverick's MVC-101 candidate.
Within the KiCS study researchers found targetable mutations in more than half of the kids, but few actually received drugs based on those molecular markers.
The funds will support continued growth in precision oncology, new product development, and new initiatives in the clinical trial and biopharmaceutical markets.
The Broad Institute's CRISPR paralog screening platform will inform Ideaya's synthetic lethality-based target and biomarker discoveries.